← FDA Drug Approvals (Drugs@FDA)

DEFERASIROX

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LTD · Approved 2023-10-16

Drug application

FDA Application #

ANDA214474

Application type

Abbreviated New Drug Application (Generic)

Brand name

DEFERASIROX

Generic name

DEFERASIROX

Active ingredients

DEFERASIROX

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

AUROBINDO PHARMA LTD

Manufacturer

NorthStar Rx LLC

First approval

2023-10-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown